These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3876336)

  • 81. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
    Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
    Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of vitamin C on androgen receptor mediated actions in human prostate adenocarcinoma cell line LAPC-4.
    Wang MH; Abreu-Delgado Y; Young CY
    Urology; 2003 Jul; 62(1):167-71. PubMed ID: 12837460
    [TBL] [Abstract][Full Text] [Related]  

  • 83. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
    Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM
    Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
    Esquenet M; Swinnen JV; Heyns W; Verhoeven G
    Mol Cell Endocrinol; 1995 Mar; 109(1):105-11. PubMed ID: 7540569
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prostate adenocarcinoma: effects of castration on in situ androgen uptake by individual cell types.
    Lippert MC; Keefer DA
    J Urol; 1987 Jan; 137(1):140-5. PubMed ID: 3795357
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function.
    Adam RM; Kim J; Lin J; Orsola A; Zhuang L; Rice DC; Freeman MR
    Endocrinology; 2002 Dec; 143(12):4599-608. PubMed ID: 12446587
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
    Attardi BJ; Burgenson J; Hild SA; Reel JR
    Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Androgen receptor binding to nuclear matrix in vitro and its inhibition by 8S androgen receptor promoting factor.
    Colvard DS; Wilson EM
    Biochemistry; 1984 Jul; 23(15):3479-86. PubMed ID: 6466649
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo.
    Zhang J; Thomas TZ; Kasper S; Matusik RJ
    Endocrinology; 2000 Dec; 141(12):4698-710. PubMed ID: 11108285
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
    Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
    Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro.
    Berthon P; Waller AS; Villette JM; Loridon L; Cussenot O; Maitland NJ
    Int J Cancer; 1997 Dec; 73(6):910-6. PubMed ID: 9399675
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK; Heston WD; Scott WW; Coffey DS
    Cancer Treat Rep; 1977; 61(2):273-87. PubMed ID: 872132
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Proliferative response of the Dunning R3327H experimental model of prostatic adenocarcinoma to conditions of androgen depletion and repletion.
    English HF; Kloszewski ED; Valentine EG; Santen RJ
    Cancer Res; 1986 Feb; 46(2):839-44. PubMed ID: 3940646
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Inhibition of growth and induction of apoptosis by androgens of a variant of LNCaP cell line.
    Joly-Pharaboz MO; Ruffion A; Roch A; Michel-Calemard L; André J; Chantepie J; Nicolas B; Panaye G
    J Steroid Biochem Mol Biol; 2000; 73(5):237-49. PubMed ID: 11070352
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The causal effect of testosterone on men's competitive behavior is moderated by basal cortisol and cues to an opponent's status: Evidence for a context-dependent dual-hormone hypothesis.
    Knight EL; Morales PJ; Christian CB; Prasad S; Harbaugh WT; Mehta PH; Mayr U
    J Pers Soc Psychol; 2022 Oct; 123(4):693-716. PubMed ID: 35201818
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.
    Kach J; Long TM; Selman P; Tonsing-Carter EY; Bacalao MA; Lastra RR; de Wet L; Comiskey S; Gillard M; VanOpstall C; West DC; Chan WC; Griend DV; Conzen SD; Szmulewitz RZ
    Mol Cancer Ther; 2017 Aug; 16(8):1680-1692. PubMed ID: 28428441
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products.
    Dean M; Murphy BT; Burdette JE
    Mol Cell Endocrinol; 2017 Feb; 442():98-105. PubMed ID: 27986590
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.
    Sundahl N; Clarisse D; Bracke M; Offner F; Berghe WV; Beck IM
    Oncoscience; 2016; 3(7-8):188-202. PubMed ID: 27713909
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Sexual selection on male vocal fundamental frequency in humans and other anthropoids.
    Puts DA; Hill AK; Bailey DH; Walker RS; Rendall D; Wheatley JR; Welling LL; Dawood K; Cárdenas R; Burriss RP; Jablonski NG; Shriver MD; Weiss D; Lameira AR; Apicella CL; Owren MJ; Barelli C; Glenn ME; Ramos-Fernandez G
    Proc Biol Sci; 2016 Apr; 283(1829):. PubMed ID: 27122553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.